Therapy News and Research

RSS

Perioperative analgesia may improve prostate cancer outcomes

Neuraxial analgesia added to general anesthesia for radical retropubic prostatectomy may lead to improved oncologic outcomes in prostate cancer, US researchers have found.

6 Jan 2014

The fight against HIV/AIDS: an interview with Dr. Mit Philips, HIV/AIDS Policy Analyst, Médecins Sans Frontières (MSF)

People mainly speak about the progress in HIV/AIDS. We at MSF know and are very conscious of the fact that there has been enormous progress, but the progress is very uneven.

6 Jan 2014

Amneal launches generic Esomeprazole strontium delayed-release capsules 49.3 mg

Amneal Pharmaceuticals LLC today announced the launch of generic Esomeprazole strontium delayed-release capsules 49.3 mg. This new esomeprazole therapy is the generic equivalent of the recently launched brand Esomeprazole strontium. It contains the same active moiety (esomeprazole) in a different salt form as found in the leading PPI brand Nexium (esomeprazole magnesium) and presents a potentially more affordable treatment option for GERD in adult patients.

6 Jan 2014

Cord Blood America achieves AABB accreditation for cell therapy activity

Cord Blood America, Inc. today announced it has achieved AABB accreditation for cell therapy activity associated with cord blood processing, storage and distribution.

6 Jan 2014

FDA grants orphan drug designation for DiaVacs' type 1 diabetes mellitus therapy

DiaVacs, Inc. announced today that the Office of Orphan Products Development of the Food and Drug Administration has granted orphan drug designation for the company's type 1 diabetes mellitus (T1DM) therapy.

6 Jan 2014

Special publication details breakthrough research on causes of vascular disease

The world's leading voices in the fight against Pulmonary Hypertension have compiled a special publication detailing the breakthrough research into the causes of this debilitating vascular disease.

6 Jan 2014

NICE issues Final Appraisal Determination for PIXUVRI (pixantrone) drug

Cell Therapeutics, Inc. (CTI) (NASDAQ and MTA: CTIC) today reported that the National Institute for Health and Care Excellence (NICE), the independent body responsible for driving improvement and excellence in the health and social care system in the United Kingdom (UK), has issued its Final Appraisal Determination (FAD) for PIXUVRI® (pixantrone).

6 Jan 2014

Environmental stresses can help trigger depression in people vulnerable to SAD, post-holiday blues

The first Monday after the holidays can be a depressing time for people coping with a post-holiday letdown and a type of depression triggered by short days called seasonal affective disorder.

6 Jan 2014

NPS Pharmaceuticals' Natpara gets orphan drug designation for treatment of hypoparathyroidism

NPS Pharmaceuticals, Inc., a global biopharmaceutical company pioneering and delivering therapies that transform the lives of patients with rare diseases, today announced that the European Commission has granted orphan drug designation to Natpara (recombinant human parathyroid hormone (rhPTH[1-84]) for the treatment of hypoparathyroidism.

3 Jan 2014

‘First-line’ role for sleep deprivation in suicidal bipolar patients

Chronotherapy, involving total sleep deprivation and light therapy, brings about a rapid reduction in suicidality among patients with bipolar disorder experiencing a phase of major depression.

3 Jan 2014

Marina Biotech, Mirna modify license agreement regarding development of microRNA-based therapeutics

Marina Biotech, Inc., a leading oligonucleotide-based drug discovery and development company, and Mirna Therapeutics, Inc., a privately-held biotechnology company pioneering microRNA replacement therapy for cancer, announced today that they have amended their license agreement regarding the development and commercialization of microRNA-based therapeutics utilizing Mirna's proprietary microRNAs and Marina Biotech's novel SMARTICLES liposomal delivery technology.

3 Jan 2014

Apple Valley Medical Clinic Sleep Center moves to 14843 Energy Way in Apple Valley

The Apple Valley Medical Clinic's Sleep Center has moved to 14843 Energy Way in Apple Valley. The center, which opened in 2010 under the medical direction of Scott Benson, M.D., a family medicine physician with the Apple Valley Medical Clinic, offers preventive care, diagnosis and referral for treatment of sleep disorders.

3 Jan 2014

Molecule produced by brain acts as natural defence mechanism against cannabis

Two INSERM research teams led by Pier Vincenzo Piazza and Giovanni Marsicano (INSERM Unit 862 "Neurocentre Magendie" in Bordeaux) recently discovered that pregnenolone, a molecule produced by the brain, acts as a natural defence mechanism against the harmful effects of cannabis in animals.

3 Jan 2014

University of Utah discovers cellular mechanism that stops metastasis of breast cancer

Researchers from Huntsman Cancer Institute (HCI) at the University of Utah discovered a cellular mechanism that drives the spread of breast cancer to other parts of the body (metastasis), as well as a therapy which blocks that mechanism. The research results were published online in the journal Cell Reports on January 2.

3 Jan 2014

City of Hope to offer radiation oncology services to patients in the Arcadia area

City of Hope and Methodist Hospital of Southern California have reached an agreement in which City of Hope will acquire the hospital's radiation oncology service in Arcadia. The acquisition will expand access to City of Hope's renowned expertise in radiation therapy and will provide additional convenience for patients seeking specialized cancer services.

2 Jan 2014

Cardiotoxicity of doxorubicin is mediated through mitochondrial iron accumulation

Doxorubicin is a widely used as a component of chemotherapy regimes; however, the use of doxorubicin is associated with severe cardiotoxicity. It is unclear exactly how doxorubicin promotes cardiotoxicity, but it has been proposed that doxorubicin-associated cardiomyopathy develops as the result of reactive oxygen species (ROS) production and iron accumulation.

2 Jan 2014

Mazor Robotics gets orders for two Renaissance systems

Mazor Robotics Ltd., the developer of Renaissance, an innovative surgical guidance system and its complementary products, announced today orders of two Renaissance systems in late December, ending the 2013 fourth quarter with a total of seven system sales. In the U.S., the system was ordered by Littleton Adventist Hospital (Littleton, CO) and the second system was ordered internationally by Bestech, the Company's distributor in Israel, for installation in a hospital in Haifa, Israel.

2 Jan 2014

Smiths Medical gets FDA clearance to market CADD-Solis system with PIB and PCA delivery in the US

Smiths Medical, a leading global medical device manufacturer, announced today it has received FDA 510(k) clearance to market its CADD-Solis pain management system version 3.0 with Programmed Intermittent Bolus and Patient Controlled Analgesics delivery in the United States. The new customizable, infusion system will help healthcare providers overcome challenges in maintaining effective epidural analgesia during labor and delivery or with post-operative pain management.

2 Jan 2014

Study finds only small therapeutic effect of CBT on schizophrenic symptoms

Health organisations around the world recommend a form of psychotherapy, known as cognitive-behavioural therapy or CBT, for patients with schizophrenia. Now, however, the most extensive study ever undertaken into its effect on the symptoms of the disorder finds little impact, according to a team of international researchers.

2 Jan 2014

Rates of smoking, drinking and drug use are higher among people with psychotic disorders

In the largest ever assessment of substance use among people with severe psychiatric illness, researchers at Washington University School of Medicine in St. Louis and the University of Southern California have found that rates of smoking, drinking and drug use are significantly higher among those who have psychotic disorders than among those in the general population.

2 Jan 2014

Therapy News and Research

Perioperative analgesia may improve prostate cancer outcomes

The fight against HIV/AIDS: an interview with Dr. Mit Philips, HIV/AIDS Policy Analyst, Médecins Sans Frontières (MSF)

Amneal launches generic Esomeprazole strontium delayed-release capsules 49.3 mg

Cord Blood America achieves AABB accreditation for cell therapy activity

FDA grants orphan drug designation for DiaVacs' type 1 diabetes mellitus therapy

Special publication details breakthrough research on causes of vascular disease

NICE issues Final Appraisal Determination for PIXUVRI (pixantrone) drug

Environmental stresses can help trigger depression in people vulnerable to SAD, post-holiday blues

NPS Pharmaceuticals' Natpara gets orphan drug designation for treatment of hypoparathyroidism

‘First-line’ role for sleep deprivation in suicidal bipolar patients

Marina Biotech, Mirna modify license agreement regarding development of microRNA-based therapeutics

Apple Valley Medical Clinic Sleep Center moves to 14843 Energy Way in Apple Valley

Molecule produced by brain acts as natural defence mechanism against cannabis

University of Utah discovers cellular mechanism that stops metastasis of breast cancer

City of Hope to offer radiation oncology services to patients in the Arcadia area

Cardiotoxicity of doxorubicin is mediated through mitochondrial iron accumulation

Mazor Robotics gets orders for two Renaissance systems

Smiths Medical gets FDA clearance to market CADD-Solis system with PIB and PCA delivery in the US

Study finds only small therapeutic effect of CBT on schizophrenic symptoms

Rates of smoking, drinking and drug use are higher among people with psychotic disorders

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News